Pfizer CFO D'Amelio to retire after 15 years at company

  • 📰 Reuters
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 97%

Ireland News News

Ireland Ireland Latest News,Ireland Ireland Headlines

Pfizer Inc said on Wednesday Chief Financial Officer Frank D'Amelio, 63, would retire after nearly 15 years at the company.

Frank D'Amelio, Executive Vice President, Business Operations and Chief Financial Officer of Pfizer Inc., arrives at Portcullis House to attend a parliamentary business and enterprise committee hearing on the future of AstraZeneca, in central London, May 13, 2014. REUTERS/Andrew Winningsaid on Wednesday Chief Financial Officer Frank D'Amelio, 63, would retire after nearly 15 years at the company.

The drugmaker has started an external search for the successor of D'Amelio, who also served as executive vice president of global supply. During his tenure, Pfizer slimmed down its business through sales to focus on its newer, patent-protected portfolio of profitable drugs such as cancer treatment Ibrance.

D'Amelio played crucial roles in the company's 2011 sale of its capsule-making unit to private equity firm KKR & Co

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in İE

Ireland Ireland Latest News, Ireland Ireland Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pfizer agrees to let other companies make its Covid pill to allow broader global accessDrugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental Covid-19 pill, a move that could make the treatment available to more than half of the world’s population.
Source: NBCNews - 🏆 10. / 86 Read more »

Pfizer agrees to let other companies make its COVID-19 pillDrugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world’s population. In a statement issued Tuesday, Pfizer said it would grant a license for the antiviral pill to the Geneva-based Medicines Patent Pool, which would let generic drug companies produce the pill for use in 95 countries, making up about 53% of the world’s population. “It’s quite significant that we will be able to provide access to a drug that appears to be effective and has just been developed, to more than 4 billion people,” Esteban Burrone, head of policy at the Medicines Patent Pool, said.
Source: YahooNews - 🏆 380. / 59 Read more »

Pfizer agrees to let other companies make its COVID-19 pillLONDON (AP) — Drugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world’s population. mikewsyx6 I ran across a documentary called 'Covid-19, Race for the Vaccine' about Pfizer's efforts to get the vaccine out. It's well worth watching. Glad they're willing to share this new pill to help people, not their bottom line. kxly4news This is all turning out to be very lucrative for pfizer. Good thing they got all that money and support from Operation Warp Speed huh? Thank you pfizer
Source: AP - 🏆 728. / 51 Read more »